touchPODCAST
By touchpodcast
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by touchpodcast
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 100
Description
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.
Educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
| Episode | Date |
|---|---|
|
touchRESPIRATORY - Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions
|
May 17, 2024 |
|
Gastrointestinal oncology experts discuss precision medicine in the treatment of colorectal cancer - MODULE 1
|
Apr 23, 2024 |
|
touchRESPIRATORY - Current treatments and unmet needs in limited-stage small cell lung cancer
|
Apr 16, 2024 |
|
touchONCOLOGY - Current treatments and unmet needs in limited-stage small cell lung cancer
|
Apr 16, 2024 |
|
How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 5
|
Mar 28, 2024 |
|
Understanding agitation in Alzheimer’s dementia – Discussion 4
|
Mar 28, 2024 |
|
Managing agitation in Alzheimer’s dementia – Discussion 3
|
Mar 28, 2024 |
|
How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 2
|
Mar 28, 2024 |
|
Understanding agitation in Alzheimer’s dementia – Discussion 1
|
Mar 28, 2024 |
|
Experts in diabetes discuss the latest developments in basal insulin therapy for type 2 diabetes management
|
Mar 28, 2024 |
|
What’s on the horizon to tackle unmet needs in recurrent metastatic SCCHN?
|
Feb 28, 2024 |
|
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
|
Feb 22, 2024 |
|
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond
|
Feb 21, 2024 |
|
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond
|
Feb 21, 2024 |
|
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
|
Feb 21, 2024 |
|
Addressing the diagnosis and management of pet allergies in primary care and beyond
|
Feb 14, 2024 |
|
Addressing the diagnosis and management of pet allergies in primary care and beyond
|
Feb 09, 2024 |
|
touchHAEMATOLOGY - The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
|
Feb 09, 2024 |
|
touchONCOLOGY - The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
|
Feb 09, 2024 |
|
touchIMMUNOLOGY - Diagnosing and treating patients with EoE: Tackling the difficulties
|
Feb 07, 2024 |
|
touchRESPIRATORY - Diagnosing and treating patients with EoE: Tackling the difficulties
|
Feb 07, 2024 |
|
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
|
Feb 06, 2024 |
|
touchMDT – Management of prurigo nodularis – Discussion 2
|
Feb 06, 2024 |
|
touchMDT – Burden of prurigo nodularis – Discussion 1
|
Feb 06, 2024 |
|
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
|
Feb 06, 2024 |
|
touchMDT – Management of prurigo nodularis – Discussion 2
|
Feb 06, 2024 |
|
touchMDT – Burden of prurigo nodularis – Discussion 1
|
Feb 06, 2024 |
|
Is HER2 targeting on the horizon for urothelial carcinoma?
|
Jan 24, 2024 |
|
Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease
|
Jan 24, 2024 |
|
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL
|
Jan 10, 2024 |
|
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL
|
Jan 10, 2024 |
|
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
|
Jan 09, 2024 |
|
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
|
Jan 09, 2024 |
|
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma
|
Jan 08, 2024 |
|
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma
|
Jan 08, 2024 |
|
Advances in IOL technology and power calculations: Updates and innovations
|
Dec 22, 2023 |
|
Guideline-based treatment of recurrent/metastatic cervical cancer
|
Dec 13, 2023 |
|
IgG4-related disease: How to identify, diagnose and treat
|
Dec 11, 2023 |
|
Paediatric atopic dermatitis: Evolving strategies for improved management
|
Dec 07, 2023 |
|
Paediatric atopic dermatitis: Evolving strategies for improved management
|
Dec 07, 2023 |
|
Optimizing the management of patients with relapsing forms of MS: An update on emerging treatment options
|
Dec 06, 2023 |
|
Cataract surgery and ocular comorbidities: Key considerations for intraocular lens choice
|
Dec 04, 2023 |
|
PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management
|
Nov 27, 2023 |
|
Clinical care pathway for Alzheimer’s disease Driving improvements in diagnosis
|
Nov 17, 2023 |
|
Using anti-CGRP antibodies for migraine prevention: Key learnings
|
Oct 30, 2023 |
|
Treatment of endometrial cancer: Highlights from ESGO 2023
|
Oct 19, 2023 |
|
Practical considerations for personalized medicine in thyroid cancer: Which therapies are suited to particular patient profiles?
|
Oct 19, 2023 |
|
Practical considerations for personalized medicine in thyroid cancer: Which therapies are suited to particular patient profiles?
|
Oct 19, 2023 |
|
Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
|
Oct 05, 2023 |
|
Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
|
Oct 05, 2023 |
|
COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in the Middle East?
|
Oct 04, 2023 |
|
COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in Africa?
|
Oct 04, 2023 |
|
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
|
Sep 21, 2023 |
|
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
|
Sep 21, 2023 |
|
Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer
|
Sep 14, 2023 |
|
Optimizing IOL selection Focus on IOL calculations in “difficult” eyes
|
Sep 11, 2023 |
|
Anti-CGRP antibody preventive treatment of migraine: Practical management
|
Aug 30, 2023 |
|
The complement system in NMOSD and MG: A target for therapeutic benefit?
|
Aug 15, 2023 |
|
The complement system in NMOSD and MG: A target for therapeutic benefit?
|
Aug 15, 2023 |
|
The complement system in NMOSD and MG: A target for therapeutic benefit
|
Aug 15, 2023 |
|
Contemporary insights on sickle cell disease complications and recent advances in therapy
|
Aug 15, 2023 |
|
Contemporary insights on sickle cell disease complications and recent advances in therapy
|
Aug 15, 2023 |
|
Contemporary insights on sickle cell disease complications and recent advances in therapy
|
Aug 15, 2023 |
|
Contemporary insights on sickle cell disease complications and recent advances in therapy
|
Aug 14, 2023 |
|
New and emerging agents in HER2-negative metastatic breast cancer Implications for current and future practice
|
Aug 14, 2023 |
|
DOACs and reversal agents for patients experiencing ICH: Latest evidence - touchCARDIOLOGY
|
Aug 10, 2023 |
|
DOACs and reversal agents for patients experiencing ICH: Latest evidence - touchNEUROLOGY
|
Aug 10, 2023 |
|
Key considerations in the management of irAEs with ICIs in advanced or recurrent endometrial cancer
|
Aug 09, 2023 |
|
Importance of shared decision making in the management of endometrial cancer
|
Aug 09, 2023 |
|
Improving outcomes with ICIs in advanced or recurrent endometrial cancer
|
Aug 09, 2023 |
|
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic - touchHAEMATOLOGY
|
Jul 31, 2023 |
|
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic - touchONCOLOGY
|
Jul 31, 2023 |
|
Preventing HPV-associated cancer by maximizing vaccine uptake
|
Jul 31, 2023 |
|
Preventing HPV-associated cancer by maximizing vaccine uptake
|
Jul 31, 2023 |
|
Fulfilling the potential of HER2-targeting in colorectal cancer
|
Jul 26, 2023 |
|
Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies - Modules 1 & 2
|
Jul 20, 2023 |
|
Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
|
Jul 18, 2023 |
|
Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
|
Jul 18, 2023 |
|
Current and future considerations for the use of immune checkpoint inhibitors in NSCLC
|
Jul 10, 2023 |
|
Current and future considerations for the use of immune checkpoint inhibitors in NSCLC
|
Jul 10, 2023 |
|
Shaping ART around individual needs: Maximizing adherence and quality of life
|
Jun 29, 2023 |
|
Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care
|
Jun 22, 2023 |
|
Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care
|
Jun 22, 2023 |
|
Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice
|
Jun 21, 2023 |
|
Key considerations for treatment selection and sequencing in patients with RRMM Lessons from real-life clinical practice
|
Jun 21, 2023 |
|
Individualizing long-term treatment and care in active MS
|
Jun 12, 2023 |
|
MDT perspectives on approaches for the use of immune checkpoint inhibitor therapy in patients with solid tumours
|
Jun 08, 2023 |
|
MDT perspectives on the role of biomarkers in informing immune checkpoint inhibitor use across tumour types
|
Jun 08, 2023 |
|
MDT perspectives on strategies for identifying and monitoring immune-related adverse events
|
Jun 08, 2023 |
|
MDT perspectives on indications for immune checkpoint inhibitors in patients with solid tumours
|
Jun 08, 2023 |
|
Adverse event identification and management in locally advanced/metastatic urothelial carcinoma
|
May 31, 2023 |
|
Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in the Middle East
|
May 30, 2023 |
|
Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
|
May 18, 2023 |
|
Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
|
May 18, 2023 |
|
Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in Africa
|
May 11, 2023 |
|
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
|
May 04, 2023 |
|
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
|
May 04, 2023 |
|
Clinical updates from SGO 2023 on PARP inhibitors in ovarian cancer
|
May 03, 2023 |
|
Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach
|
Apr 24, 2023 |
|
Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach
|
Apr 24, 2023 |